MabThera is the first and only selective B cell therapy for RA, providing a fundamentally different treatment approach by targeting B cells, one of the key players in the pathogenesis of RA.
英
美
- 美羅華是首類(lèi)也是唯一一種風(fēng)濕性關(guān)節炎選擇性B細胞療法，它通過(guò)殺死B細胞而提供了一種截然不同的療法，B細胞在風(fēng)濕性關(guān)節炎的發(fā)病機理中起著(zhù)關(guān)鍵作用。
